Clinical trial phase III, multicenter, randomised, double-blind, double-dummy, parallel treatment design, active-controlled and placebo, to evaluate the analgesic efficacy and safety of ibuprofen arginine/tramadol 400/37.5 mg compared to ibuprofen arginine 400 mg single, tramadol 50 mg single and placebo in patients with moderate to severe pain after dental surgery.

Trial Profile

Clinical trial phase III, multicenter, randomised, double-blind, double-dummy, parallel treatment design, active-controlled and placebo, to evaluate the analgesic efficacy and safety of ibuprofen arginine/tramadol 400/37.5 mg compared to ibuprofen arginine 400 mg single, tramadol 50 mg single and placebo in patients with moderate to severe pain after dental surgery.

Completed
Phase of Trial: Phase III

Latest Information Update: 26 May 2015

At a glance

  • Drugs Ibuprofen arginine/tramadol (Primary) ; Ibuprofen; Tramadol
  • Indications Dental pain
  • Focus Therapeutic Use
  • Sponsors Farmalider
  • Most Recent Events

    • 23 May 2015 Status changed from recruiting to completed as per European Clinical Trials Database record.
    • 10 Feb 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top